Lamina Therapeutics is a biotechnology company developing a new generation of implantable medical devices for regenerative medicine
Cartilage and bone damage in the knee affects millions of people, becoming an increasing medical problem. This damage is mostly caused by joint injury affecting relatively young and active people, resulting in pain and mobility issues. Cartilage does not have self-healing capabilities and if left untreated this damage can lead to chronic osteoarthritis, a progressive disease with no cure. There is a great need for innovative technologies to efficiently prevent cartilage degradation at an early stage and restore stable articular cartilage in localized chondral defects.
Lamina’s technology consists of a three-dimensional biodegradable wound dressing with nano-reservoirs including active therapeutics in combination with patient’s own stem cells. This unique multifunctional approach offers a variety of potential applications addressing unmet medical needs in the field of orthopaedics, maxillofacial and periodontal lesions.
News from Lamina
Read More →
Strasbourg welcomes a new start-up in its land of scientific excellence: LAMINA THERAPEUTICS, based on an innovative technology emerging from INSERM and the University of
Visit us in Illkirch
Meet our team? Drop by for a coffee and a chat.